![Brent Sabatini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brent Sabatini
Comptroller/Controller/Auditor chez
VIR BIOTECHNOLOGY, INC.
Fortune : 630 781 $ au 30/06/2026
Profil
Brent Sabatini is currently Chief Accounting Officer & Senior Vice President at Vir Biotechnology, Inc. since 2024.
Formerly, Mr. Sabatini was Head-Finance at Capsida Biotherapeutics, Inc. from 2021 to 2023.
Education includes an MBA from Stephen M.
Ross School of Business and an undergraduate degree from The California State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2026 | 61 902 ( 0,04% ) | 630 781 $ | 30/06/2026 |
Postes actifs de Brent Sabatini
| Sociétés | Poste | Début |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Comptroller/Controller/Auditor | 01/01/2023 |
Anciens postes connus de Brent Sabatini
| Sociétés | Poste | Fin |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Corporate Officer/Principal | 01/02/2023 |
Formation de Brent Sabatini
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The California State University
 The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
